34733158|t|Securidaca inappendiculata Polyphenol Rich Extract Counteracts Cognitive Deficits, Neuropathy, Neuroinflammation and Oxidative Stress in Diabetic Encephalopathic Rats via p38 MAPK/Nrf2/HO-1 Pathways.
34733158|a|Diabetic encephalopathy is one of the serious emerging complication of diabetes. Securidaca inappendiculata is an important medicinal plant with excellent antioxidant and anti-inflammatory properties. This study investigated the neuroprotective effects of S. inappendiculata polyphenol rich extract (SiPE) against diabetic encephalopathy in rats and elucidated the potential mechanisms of action. Type 2 diabetes mellitus (T2DM) was induced using high fructose solution/intraperitoneal injection of streptozotocin and the diabetic rats were treated with SiPE (50, 100 and 200 mg/kg) for 8 weeks. Learning and memory functions were assessed using the Morris water and Y maze tests, depressive behaviour was evaluated using forced swimming and open field tests, while neuropathic pain assessment was assessed using hot plate, tail immersion and formalin tests. After the experiments, acetylcholinesterase (AChE), oxidative stress biomarkers and proinflammatory cytokines, caspase-3 and nuclear factor kappa-light-chain-enhancer of activated B (NF-kappaB) were determined by ELISA kits. In addition, the expression levels of p38, phospho-p38 (p-p38), nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) were determined by western blot analyses. The results indicated that SiPE administration significantly lowered blood glucose level, attenuated body weight loss, thermal/chemical hyperalgesia, improved behavioural deficit in the Morris water maze, Y maze test and reduced depressive-like behaviours. Furthermore, SiPE reduced AChE, caspase-3, NF-kappaB, malonaldehyde malondialdehyde levels and simultaneously increased antioxidant enzymes activity in the brain tissues of diabetic rats. SiPE administration also significantly suppressed p38 MAPK pathway and upregulated the Nrf2 pathway. The findings suggested that SiPE exerted antidiabetic encephalopathy effects via modulation of oxidative stress and inflammation.
34733158	0	26	Securidaca inappendiculata	Species	
34733158	27	50	Polyphenol Rich Extract	Chemical	-
34733158	63	81	Cognitive Deficits	Disease	MESH:D003072
34733158	83	93	Neuropathy	Disease	MESH:D009422
34733158	95	112	Neuroinflammation	Disease	MESH:D000090862
34733158	137	161	Diabetic Encephalopathic	Disease	MESH:D003920
34733158	162	166	Rats	Species	10116
34733158	180	184	Nrf2	Gene	83619
34733158	185	189	HO-1	Gene	24451
34733158	200	223	Diabetic encephalopathy	Disease	MESH:C000721848
34733158	271	279	diabetes	Disease	MESH:D003920
34733158	281	307	Securidaca inappendiculata	Species	
34733158	376	388	inflammatory	Disease	MESH:D007249
34733158	456	498	S. inappendiculata polyphenol rich extract	Chemical	-
34733158	500	504	SiPE	Chemical	-
34733158	514	537	diabetic encephalopathy	Disease	MESH:C000721848
34733158	541	545	rats	Species	10116
34733158	597	621	Type 2 diabetes mellitus	Disease	MESH:D003924
34733158	623	627	T2DM	Disease	MESH:D003924
34733158	652	660	fructose	Chemical	MESH:D005632
34733158	699	713	streptozotocin	Chemical	MESH:D013311
34733158	722	730	diabetic	Disease	MESH:D003920
34733158	731	735	rats	Species	10116
34733158	754	758	SiPE	Chemical	-
34733158	881	891	depressive	Disease	MESH:D003866
34733158	966	982	neuropathic pain	Disease	MESH:D009437
34733158	1043	1051	formalin	Chemical	MESH:D005557
34733158	1082	1102	acetylcholinesterase	Gene	83817
34733158	1104	1108	AChE	Gene	83817
34733158	1170	1179	caspase-3	Gene	25402
34733158	1322	1325	p38	Gene	81649
34733158	1335	1338	p38	Gene	81649
34733158	1342	1345	p38	Gene	81649
34733158	1348	1391	nuclear factor erythroid 2-related factor 2	Gene	83619
34733158	1393	1397	Nrf2	Gene	83619
34733158	1403	1419	heme oxygenase-1	Gene	24451
34733158	1421	1425	HO-1	Gene	24451
34733158	1496	1500	SiPE	Chemical	-
34733158	1538	1551	blood glucose	Chemical	MESH:D001786
34733158	1575	1586	weight loss	Disease	MESH:D015431
34733158	1588	1617	thermal/chemical hyperalgesia	Disease	MESH:D006930
34733158	1628	1647	behavioural deficit	Disease	MESH:D001289
34733158	1698	1708	depressive	Disease	MESH:D003866
34733158	1739	1743	SiPE	Chemical	-
34733158	1752	1756	AChE	Gene	83817
34733158	1758	1767	caspase-3	Gene	25402
34733158	1780	1793	malonaldehyde	Chemical	MESH:D008315
34733158	1794	1809	malondialdehyde	Chemical	MESH:D008315
34733158	1899	1907	diabetic	Disease	MESH:D003920
34733158	1908	1912	rats	Species	10116
34733158	1914	1918	SiPE	Chemical	-
34733158	2001	2005	Nrf2	Gene	83619
34733158	2043	2047	SiPE	Chemical	-
34733158	2069	2083	encephalopathy	Disease	MESH:D001927
34733158	2131	2143	inflammation	Disease	MESH:D007249
34733158	Association	MESH:D005557	MESH:D009437
34733158	Positive_Correlation	MESH:D005632	MESH:D003924
34733158	Positive_Correlation	MESH:D013311	MESH:D003924

